Technical Analysis for OMGA - Omega Therapeutics, Inc.

Grade Last Price % Change Price Change
F 9.365 -2.04% -0.20
OMGA closed down 10.32 percent on Tuesday, January 18, 2022, on 79 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical OMGA trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish -2.04%
180 Bearish Setup Bearish Swing Setup -2.04%
New 52 Week Low Weakness -2.04%
Multiple of Ten Bearish Other -2.04%
Wide Bands Range Expansion -2.04%
Oversold Stochastic Weakness -2.04%
New 52 Week Low Weakness -12.15%
Multiple of Ten Bullish Other -12.15%
Outside Day Range Expansion -12.15%
Wide Bands Range Expansion -12.15%
Older End-of-Day Signals for OMGA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 27 minutes ago
Down 3% 27 minutes ago
Bearish 180 Entry about 1 hour ago
Fell Below Previous Day's Low about 1 hour ago
Down 2 % about 1 hour ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Omega Therapeutics, Inc., a biotechnology company, develops genomic medicines to cure diseases. The company focuses on precision tuning to activate the human genome's native capacity to treat and cure diseases. It engages in designing, engineering, and manufacturing Epigenomic Controllers to target the GenomStats for the cell types of interest, with the ability to downregulate or upregulate genomic activity for therapeutic effect. Omega Therapeutics, Inc. was formerly known as VL42, Inc. and changed its name to Omega Therapeutics, Inc. in July 2017. The company was incorporated in 2016 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Human Genome

Is OMGA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.41
52 Week Low 9.49
Average Volume 84,400
200-Day Moving Average 0.00
50-Day Moving Average 15.56
20-Day Moving Average 12.14
10-Day Moving Average 10.98
Average True Range 1.34
ADX 33.16
+DI 9.21
-DI 26.87
Chandelier Exit (Long, 3 ATRs) 11.73
Chandelier Exit (Short, 3 ATRs) 13.51
Upper Bollinger Bands 15.32
Lower Bollinger Band 8.96
Percent B (%b) 0.09
BandWidth 52.32
MACD Line -1.58
MACD Signal Line -1.55
MACD Histogram -0.0328
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.35
Resistance 3 (R3) 11.52 11.10 11.05
Resistance 2 (R2) 11.10 10.65 11.01 10.95
Resistance 1 (R1) 10.33 10.36 10.12 10.16 10.85
Pivot Point 9.91 9.91 9.81 9.82 9.91
Support 1 (S1) 9.14 9.46 8.93 8.97 8.27
Support 2 (S2) 8.72 9.17 8.63 8.17
Support 3 (S3) 7.95 8.72 8.07
Support 4 (S4) 7.78